ketoconazole has been researched along with mdv 3100 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, W; Ryan, CJ | 1 |
| Burns, J; Caram, MEV; Hollenbeck, BK; Kumbier, K; Shahinian, V; Skolarus, TA; Sparks, JB; Stensland, KD; Tsao, PA; Washington, SL | 1 |
1 review(s) available for ketoconazole and mdv 3100
| Article | Year |
|---|---|
Androgen receptor directed therapies in castration-resistant metastatic prostate cancer.
Topics: Androgen Receptor Antagonists; Androstenes; Androstenols; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Benzamides; Docetaxel; Drug Resistance, Neoplasm; Humans; Ketoconazole; Male; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostatic Neoplasms; Receptors, Androgen; Steroid 17-alpha-Hydroxylase; Taxoids; Thiohydantoins | 2012 |
2 other study(ies) available for ketoconazole and mdv 3100
| Article | Year |
|---|---|
Singapore Cancer Network (SCAN) Guidelines for the Management of Advanced Castrate-Resistant Prostate Cancer.
Topics: Adenocarcinoma; Androgen Antagonists; Androstenes; Antineoplastic Agents; Benzamides; Cancer Vaccines; Docetaxel; Gonadotropin-Releasing Hormone; Humans; Ketoconazole; Male; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Singapore; Taxoids; Tissue Extracts | 2015 |
Differential adoption of castration-resistant prostate cancer treatment across facilities in a national healthcare system.
Topics: Delivery of Health Care; Docetaxel; Humans; Ketoconazole; Male; Prostatic Neoplasms, Castration-Resistant; Taxoids; Treatment Outcome | 2023 |